Plasmalogen Pharmaceutical

Plasmalogen Pharmaceutical is a Japanese biotechnology company specialized in the research, development, and commercialization of plasmalogen-based therapies and supplements. The company focuses on neurodegenerative diseases, particularly Alzheimer's disease, based on the hypothesis that plasmalogen deficiency is a key factor in cognitive decline. They have developed proprietary methods for extracting high-purity plasmalogens from natural sources such as scallops and poultry. Their products are supported by clinical research conducted in collaboration with Japanese medical institutions. Plasmalogen Pharmaceutical aims to provide therapeutic solutions for dementia and other age-related conditions through lipid-based interventions.